Anderson Thomas
SEC CIK 1612903 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| ZVRA | ZEVRA THERAPEUTICS, INC. | Dir | 20.0K | $116.9K | — | 2 | 2023-09-06 | 2024-07-16 |
Most active insiders at ZVRA, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | McFarlane Neil F. | Pres, CEO, Dir | — | $1.19M |
| 2 | Thompson Rahsaan | Chief Legal, Compliance, Sec | — | $969.4K |
| 3 | Watton Corey Michael | Dir | — | $138.4K |
| 4 | Schafer Joshua | CCO | — | $126.3K |
| 5 | Sangiovanni Timothy J. | SVP, Fin, Corp Ctrl | — | $43.0K |
| 6 | Quartel Adrian W | Chief Medical Off | — | $40.0K |
| 7 | Bode John B | Dir | — | — |
| 8 | Clifton R. LaDuane | Former CFO, Treas | — | — |
Anderson Thomas made no open-market trades at ZVRA in the last 12 months.
Transactions 2
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-07-16 | 2024-07-16 | ZVRA | ZEVRA THERAPEUTICS, INC. | Anderson Thomas | Dir | P - Purchase | $6.81 | +10.0K | 20.0K | +100% | +$68.1K | |
| 2023-09-06 | 2023-09-06 | ZVRA | ZEVRA THERAPEUTICS, INC. | Anderson Thomas | Dir | P - Purchase | $4.88 | +10.0K | 10.0K | New | +$48.8K |
Purchase Sale Sale after option exercise All abbreviations